Patent · US Active

Beta-glucan assay methods

US10114027B2 · kind B2 · utility

1Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2017
Grant dateOct 30, 2018
Priority date
Expiry dateDec 18, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

This disclosure provides, in one aspect, a method for analyzing a sample from a subject for a biomarker that is indicative of the subject's immune response to β-glucan. Generally, the method includes obtaining a biological sample from a subject, analyzing the sample for a biomarker anti-β-glucan antibody compared to a reference standard, computing a Relative Antibody Unit (RAU) value for anti-β-glucan antibody in the sample, and identifying the subject as biomarker positive if the RAU value is greater than a predetermined RAU value for the biomarker anti-β-glucan antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.